FDA Drug Recalls

11,815 recalls · Class II, newest first

Class II · Moderate risk Terminated Mar 10, 2014

Lupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilled dual-chamber syringe, 7.5 mg…

Reason Defective Delivery System: Some Lupron Depot Kits may containin a syringe with a potentially defective LuproLoc needle stick protection device.

AbbVie Inc NDC 0074-3642-03 D-1291-2014

Class II · Moderate risk Terminated Mar 10, 2014

Lupron Depot (leuprolide acetate for depot suspension) Single Dose Administration Kit with prefilled dual-chamber syringe, 11.25…

Reason Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.

AbbVie Inc NDC 0074-3663-03 D-1290-2014

Class II · Moderate risk Terminated Mar 10, 2014

LUPRON DEPOT-PED (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilled dual-chamber syringe…

Reason Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.

AbbVie Inc NDC 0074-3779-03 D-1289-2014

Class II · Moderate risk Terminated Mar 10, 2014

Lupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilled dual-chamber syringe, 45 mg…

Reason Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.

AbbVie Inc NDC 0074-3473-03 D-1288-2014

Class II · Moderate risk Terminated Mar 10, 2014

Lupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilled dual-chamber syringe, 22.5…

Reason Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.

AbbVie Inc NDC 0074-3346-03 D-1287-2014

Class II · Moderate risk Terminated Mar 4, 2014

Zoledronic Acid Injection 5 mg per 100 mL (0.05 mg/mL), 100 mL single-use bag packaged in a foil overwrap, Rx only, Sterile, For…

Reason Lack of Assurance of Sterility; leaking of premix bags

Sagent Pharmaceuticals Inc NDC 25021-830-82 D-1615-2014

Class II · Moderate risk Terminated Mar 4, 2014

VIVITROL (naltrexone for extended-release injectable suspension); 380 mg vial NDC 65757-300-01; RX Only Manufactured and…

Reason Customer complaints for failure to deliver the dose.

Alkermes, Inc. NDC 65757-300-01 D-1556-2014

Class II · Moderate risk Terminated Mar 4, 2014

Duloxetine Delayed-Release Capsules, USP, 60 mg, Rx Only, 30 Capsules per Bottle, Manufactured in Israel by: Teva Pharmaceutical…

Reason Failed Tablet/Capsule Specifications: Teva Pharmaceuticals USA, is voluntarily recalling certain lots of Duloxetine DR Capsules USP, 20 mg, 30 mg &…

Teva Pharmaceuticals USA NDC 0093-7544-56 D-1184-2014

Class II · Moderate risk Terminated Mar 4, 2014

Duloxetine Delayed-Release Capsules, USP, 30 mg, Rx Only, 30 Capsules per Bottle, Manufactured in Israel by: Teva Pharmaceutical…

Reason Failed Tablet/Capsule Specifications: Teva Pharmaceuticals USA, is voluntarily recalling certain lots of Duloxetine DR Capsules USP, 20 mg, 30 mg &…

Teva Pharmaceuticals USA NDC 0093-7543-56 D-1183-2014

Class II · Moderate risk Terminated Mar 4, 2014

Duloxetine Delayed-Release Capsules, USP, 20 mg, Rx Only, 60 capsules per Bottle, Manufactured in Israel by: Teva Pharmaceutical…

Reason Failed Tablet/Capsule Specifications: Teva Pharmaceuticals USA, is voluntarily recalling certain lots of Duloxetine DR Capsules USP, 20 mg, 30 mg &…

Teva Pharmaceuticals USA NDC 0093-7542-06 D-1182-2014

Class II · Moderate risk Terminated Mar 3, 2014